CX 2017 Presentations
Please note: Some presentations may not be available as permission may not have been given.
VENOUS CONSENSUS - Tuesday, 25th April
Venue: Lower Main Auditorium
PATHWAYS OF CARE
Time: 08:00 - 18:00
Investigations of superficial and deep venous anatomy
Time: 08:00 - 10:00
| Chairing: | Ian Franklin, London, United Kingdom |
| Moderator: | Stephen Black, London, United Kingdom |
WHETHER to intervene
Time: 08:00 - 09:02
Time: 08:00 - 08:07
The best imaging modality - the implication of cost
| Speaker: | Alun Davies, London, United Kingdom |
Time: 08:07 - 08:14
Computed tomography (CT) venography and magnetic resonance (MR) venography are performed in the horizontal position - suitability for assessing venous function and the value of IVUS
| Speaker: | Andrew Wigham, Oxford, United Kingdom |
Time: 08:14 - 08:21
Value of fusion imaging to treat deep venous thrombosis
| Speaker: | Adrien Hertault, Lille, France |
Time: 08:31 - 08:38
The place of ultrasound for deep venous assessment
| Speaker: | Fabrizio D'Abate, London, United Kingdom |
Time: 08:38 - 08:45
Haemodynamic assessment of venous reflux and obstruction
| Speaker: | Andrew Nicolaides, London, United Kingdom |
Time: 08:45 - 08:52
Analysis of threshold stenosis by multi-planar venogram and IVUS for predicting clinical Improvement after iliofemoral vein stenting
| Speaker: | Paul Gagne, Darien, United States |
Assessment and intervention of acute and chronic disease of the deep venous system
Time: 09:02 - 10:00
| Chairing: | Ian Franklin, London, United Kingdom |
| Stephen Black, London, United Kingdom |
INTERVENTION METHOD
Time: 09:02 - 10:00
WHEN to intervene
Time: 09:02 - 10:00
Time: 09:02 - 09:10
Why are so many venous stents deployed for swollen legs?
| Speaker: | Lowell Kabnick, New York, United States |
Time: 09:10 - 09:17
Pathways of care for venous stenting interventions
| Speaker: | Manj Gohel, Cambridge, United Kingdom |
Time: 09:17 - 09:24
Best medical and pharmacological treatment for post-thrombotic syndrome
| Speaker: | Arkadiusz Jawien, Bydgoszcz, Poland |
Time: 09:34 - 09:44
Treatment for acute deep venous thrombosis - pathways of care on the use of catheter-directed thrombolysis and mechanical thrombectomy
| Speaker: | Rick de Graaf, Friedrichshafen, Germany |
Time: 09:44 - 09:51
ATTRACT TRIAL - medical treatment versus intervention (pharmocomechanical thrombolysis)
| Speaker: | Suresh Vedantham, Saint Louis, United States |
COFFEE
Time: 10:00 - 10:30
Industry Sponsored Satellite
Time: 10:00 - 10:30
Assessment and intervention of acute and
established superficial and deep venous thrombosis (continued)
Time: 10:30 - 12:30
| Chairing: | Alun Davies, London, United Kingdom |
| Moderator: | Lowell Kabnick, New York, United States |
Time: 10:30 - 10:38
Patient choice in deploying a deep venous stent
| Speaker: | Ramon Varcoe, Randwick, Australia |
Time: 10:38 - 10:46
VIVO - EU stent results for symptomatic iliofemoral venous outflow obstruction
| Speaker: | Narayan Karunanithy, London, United Kingdom |
Time: 10:46 - 10:54
Effective venous thrombectomy followed by stenting
| Speaker: | Michael Lichtenberg, Arnsberg, Germany |
Time: 11:04 - 11:12
Complex endovascular inferior vena cava reconstruction
| Speaker: | Nils Kucher, Zürich, Switzerland |
Time: 11:12 - 11:20
Deep venous stenting for chronic venous disease - stenting of the iliac tract
| Speaker: | Erin Murphy, Charlotte, United States |
Time: 11:30 - 11:38
VERNACULAR iliac venous stent study
| Speaker: | Rick de Graaf, Friedrichshafen, Germany |
Time: 11:38 - 11:46
Use of deep venous stents - flexibility versus strength
| Speaker: | Stephen Black, London, United Kingdom |
Time: 11:46 - 11:54
Decision-making in the choice of anticoagulants and length of treatment following deep venous stenting
| Speaker: | Adam Gwozdz, London, United Kingdom |
Time: 12:04 - 12:12
Endophlebectomy and fistula - necessity and at what risk
| Speaker: | Houman Jalaie, Aachen, Germany |
Time: 12:12 - 12:20
The current role for the use of inferior vena cava filters - indications and contraindications
| Speaker: | Gerard Goh, Victoria, Australia |
LUNCH
Time: 12:30 - 13:30
Industry Sponsored Satellite
Time: 12:30 - 13:00
Lunch break and visit hands-on techniques
Time: 13:00 - 13:30
Upper limb/subclavian vein compression
Time: 13:30 - 13:54
| Chairing: | John Thompson, Exeter, United Kingdom |
| Moderator: | Alun Davies, London, United Kingdom |
Time: 13:30 - 13:37
Conservative treatment of Paget Schrötter syndrome
| Speaker: | Kaj Johansen, Seattle, United States |
Time: 13:37 - 13:44
Treatment of subclavian vein compression/central veins occlusions
| Speaker: | Narendra Nath Khanna, New Delhi, India |
Pelvic vein congestion and reflux
Time: 13:54 - 14:19
Time: 13:54 - 14:01
Prevalence of pelvic vein venous reflux and criteria for treatment
| Speaker: | Kathleen Gibson, Bellevue, United States |
Time: 14:01 - 14:08
Prevalence of pelvic vein incompetence in women with chronic pelvic pain and influence on quality of life
| Speaker: | Charles McCollum, Manchester, United Kingdom |
Varicose vein management
Time: 14:19 - 15:30
| Chairing: | Stephen Black, London, United Kingdom |
| Moderator: | Ian Franklin, London, United Kingdom |
INTERVENTION METHOD and outcomes
Time: 14:19 - 15:30
Time: 14:19 - 14:26
Endovenous adhesive vs. radiofrequency ablation at three years - VeClose study
| Speaker: | Kathleen Gibson, Bellevue, United States |
Time: 14:26 - 14:33
Predictors of recanalisation after cyanoacrylate truncal vein treatment
| Speaker: | Yiu Che Chan, Hong Kong, China |
Time: 14:33 - 14:40
Biomatrix sclerofoam as a rival for endothermal ablation
| Speaker: | Johann Christoph Ragg, Berlin, Germany |
Time: 14:40 - 14:47
Mechanochemical ablation of varicose veins - present evidence and indications
| Speaker: | Steve Elias, Englewood, United States |
Time: 14:58 - 15:05
Anti-venous thrombosis protocol - a proposed scoring system
| Speaker: | Isaac Nyamekye, Worcester, United Kingdom |
Time: 15:05 - 15:12
A compression system to improve working compression pressure
| Speaker: | Torbjorn Lundh, Gothenburg, Sweden |
Time: 15:12 - 15:19
Endovenous adhesive occlusion for advanced superficial venous disease - WAVES study data at 12 months
| Speaker: | Kathleen Gibson, Bellevue, United States |
TEA
Time: 15:30 - 16:00
Industry Sponsored Satellite
Time: 15:30 - 16:00
Aesthetic phlebology
Time: 16:00 - 16:33
| Chairing: | Peter Mortimer, London, United Kingdom |
| Moderator: | Ian Franklin, London, United Kingdom |
WHETHER to intervene
Time: 16:00 - 16:27
WHEN to intervene
Time: 16:00 - 16:27
INTERVENTION METHOD and FOLLOW-UP
Time: 16:00 - 16:33
Time: 16:00 - 16:08
Optimising cosmetic outcomes for reticular veins and telangiectasia
| Speaker: | Albert-Adrien Ramelet, Montcherand, Switzerland |
Time: 16:08 - 16:16
Foam sclerotherapy for reticular veins and telangiectasia
| Speaker: | Claudine Hamel-Desnos, Caen, France |
Lymphoedema
Time: 16:33 - 17:12
WHETHER to intervene
Time: 16:33 - 17:12
Time: 16:33 - 16:41
Modern understanding of primary lymphatic dysplasias and prognosis
| Speaker: | Sahar Mansour, London, United Kingdom |
Time: 16:41 - 16:49
Overview of lymphatic imaging techniques
| Speaker: | John Rasmussen, Houston, United States |
Time: 16:49 - 16:57
Surgical procedures for lymphoedema
| Speaker: | Joannis Constantinides, London, United Kingdom |
Leg ulceration
Time: 17:12 - 17:52
INTERVENTION METHOD and outcomes
Time: 17:12 - 17:52
Time: 17:12 - 17:20
Modern guidelines for leg ulceration
| Speaker: | Keith Poskitt, Cheltenham, United Kingdom |
Time: 17:21 - 17:29
Biological strategies for wound healing
| Speaker: | Muholan Kanapathy, London, United Kingdom |
Time: 17:29 - 17:37
Pathways of care - early venous reflux ablation (EVRA)
| Speaker: | Manj Gohel, Cambridge, United Kingdom |